Skip Navigation
BUSINESS ARCHITECTURE MODEL (BAM) —
National Cancer Institute   U.S. National Institutes of Health www.cancer.gov
Home » Workspaces » Clinical Trial Management Systems » BUSINESS ARCHITECTURE MODEL (BAM)
Document Actions

BUSINESS ARCHITECTURE MODEL (BAM)


The Business Architecture Model is part of the Clinical Trials Management Systems (CTMS) Workspace.

The Translational Research in Medicine Business Architecture Model (BAM) is designed to describe the activities, goals, and people involved in biomedical research, including clinical trials, laboratory research, and the organizational needs required to support these activities. The model will include diagrams and descriptions (often called process maps that make up an overall model) that show how biomedical research is generally done. For example, initial process maps for clinical research include developing an initial clinical study plan, conducting the clinical study with patients, and then writing up the results of that study. Process maps in the area of life sciences (which include biospecimen management and genomic research) are also in early development.

Ultimately, the process maps will include a broad scope of biomedical research activities being done by a large range of organizations, including the National Cancer Institute, Cooperative Groups, Cancer Centers, Community Clinical Oncology Programs (CCOP), and other governmental and private entities.

Read more in our Overview Fact Sheet about the Business Architecture Model (BAM)



How Can I Help?


The BAM team needs help from clinical specialists, research subject matter experts, and patient advocate representatives to continue to develop, validate, deepen, and expand the different process elements of the draft model developed to date.

  • If you are a researcher or clinical specialist, we’d like you to review the existing draft model for accuracy and completion. Are the appropriate activities captured? Are steps or people missing? What tools assist you in your work now? Where would different or new tools be most helpful along the process? We are also seeking participants to help future model development.
  • If you are a patient or patient advocate, we’d like you to review the model to see if the patient’s role is captured properly. How could the patient be better represented?

Here are some first steps:

  • Browse the BAM: If you want to explore the model on your own and submit comments, you can access it from the "Participants Shortcut" box above. You can also contact the BAM team to identify the groups working on specific elements of the model, and based on your experience and interest, become involved in reviews or future development of the model. For more information contact a CTMS analyst at caBIG_ctms_analyst_L@mail.nih.gov.
  • The BAM is presented using specific formats and vocabularies used by technical specialists to represent activities, people, and outputs. For example, in the model, people are often called “actors,” because they are “acting out” certain roles in the research process. Groups of activities are often called “use cases,” because they describe a “case” in which a “user” interacts with a process or system. Before reviewing the model, familiarize yourself with the model format and vocabulary using the glossary available on the BAM website above.
  • Join a Working Group: For the current working group schedule please go to CTMS's schedule page.



Release BAM v 2.1 Content


The caBIG® Translational Research in Medicine Business Architecture Model Release 2.1 is available in an html representation, a report document, and a package file that includes the release notes, Enterprise Architect file, and xmi file.



For additional information, previous releases and updates visit the BAM wiki.

Participant Shortcuts

last modified 01-11-2013 12:47 AM